The digital pathology landscape is evolving at an electrifying pace. As the industry matures, the pathways to tangible value and strategic revenue generation are becoming clearer. A recent article analyzing…
Read More
Related posts: New Digital Cancer Diagnostics Partnership Announced Between Lumea and Southern Utah University Lumea, AIRA Matrix, and Acupath have Partnered to Provide a Diagnostic AI Solution for the URO17®…
We’re excited to share that Lumea will be participating as a Technology Partner and Exhibitor at the upcoming Transforming Digital Pathology & AI: The Path Forward conference, taking place on…
The future of pathology isn’t just digital—it’s integrated. As precision medicine continues to advance, the need for seamless coordination between pathology and molecular diagnostics has never been greater. However, traditional…
A Summary of Staci Kearney’s presentation at the Digital Diagnostic Summit 2024 The Current State of the FDA’s Final Rule On May 6, 2024, the FDA issued its final rule…
AI has been a huge buzzword in pathology, but are the benefits worth the hype for prostate cancer? It’s true that AI can enhance digital prostate pathology by supporting diagnostic…
Laboratories worldwide are united by a commitment to excellence, whether in service, research, or the quality of their slides. However, beneath this shared dedication lies a diversity of resources, tools,…
“We’re all doctors. We all got into this field for a reason: the patient is central to everything we do. Using Lumea technology simply results in a better end product…
Join us on PathPulse, the Digital Diagnostic Podcast, as we delve into the groundbreaking journey of Dr. Matthew O. Leavitt, a Stanford-trained pathologist and visionary leader in digital pathology. Host…
Related posts: The Lumea BxChip® Saves Labs Time, Money, and Improves Quality Lumea Selects Tempus to Advance AI-Driven Digital Pathology Solutions Lumea Partners with P4 Diagnostix® in First Integrated LIS…
